|
|
memantine.com - A new meta analysis of Memantine in moderate to severe ...
A new meta analysis of Memantine in moderate to severe Alzheimer's disease ... This meta analysis confirms the efficacy of memantine across all domains of the ...
memantine.com - Resource utilisation and cost analysis of memantine in ...
Resource utilisation and cost analysis of memantine in patients with moderate to ... Analysis of residential status also favoured memantine: time to ...
Namenda (Memantine), Alzheimer's medication
Namenda (Memantine)is a medication used in the treatment of Alzheimer's. ... Using an analysis based on all patients and carrying their last study ...
Trends-in-Medicine
An Alzheimer's expert offered this analysis of the severe AD market ... FDA Analysis of Memantine Trial 9605 by MMSE. Measure. Placebo vs. memantine. MMSE <10 ...
Pharmacological Implications of Two Distinct Mechanisms of Interaction ...
... accuracy of Protection-SCAM analysis at steady state because memantine remains ... D, dose-response analysis of memantine and amantadine blockade of 200 µM NMDA ...
Memantine for dementia.
... of memantine in patients with moderate to severe Alzheimer's disease: analysis of the change from ... a benefit in favour of memantine (10 mg/day) compared ...
Clinical Experience of Memantine in Alzheimer's Disease | Neurology
... CH, Schmitt FA, Olin JT, A responder analysis of memantine treatment in patients ... B, Stoffler A, et al., Resource utilisation and cost analysis of memantine ...
PBM Drug Monograph Template
benefit by memantine treatment: a subgroup analysis of two placebo controlled ... B, Stöffler A, et al. Resource utilization and cost analysis of memantine in ...
Alzforum: Drugs In Clinical Trials - Memantine
The Alzheimer Research Forum, a dynamic online scientific knowledge base, reports on the latest Alzheimer's scientific research and develops databases of genes, ...
Memantine
excluded from the analysis. The Clinical Impression of ... and cost analysis of memantine in. patients with moderate to severe. Alzheimer's disease. ...
|
|
|
|
Analysis of memantine |
Resource Utilisation and Cost Analysis of Memantine in Patients with Moderate to Severe Alzheimer's Disease
[ Papers |
Articles |
Software |
Books |
Chapters |
Authors |
Institutions |
JEL Classification |
NEP reports |
Search |
New papers by email |
Author registration |
Rankings |
Volunteers |
FAQ |
Blog |
Help! ]
Background: Alzheimer's disease (AD) is a devastating illness that causes enormous emotional stress to affected families and is associated with substantial medical and nonmedical costs. Objective: To determine the effects of 28 weeks of memantine treatment for patients with AD on resource utilisation and costs. Study design and methods: Multicentre, prospective, double-blind, randomised, placebo-controlled clinical trial performed in the US. The Wilcoxon-Mann-Whitney test was used to examine the resource utilisation variables and logistic regression models were used for multivariate resource utilisation analyses.
|
Rating: 3.5 èç 5 (ãîëîñîâ: 151) |
|
7 november 2008
Ãåíàäèé Íîâèêîâ
|
|
|
|
|
and memantine
memantine for alzheimer's
memantine in patients
memantine clinical
|
|
|
|
|
Forest Laboratories, Inc Q1 2009 Earnings Call Transcript
Seeking Alpha - Apr 21, 2009
The NDA for memantine ER is completed and waiting in the wings as we continue to monitor the patent litigation activities around Namenda. ...
FRX
CATIE-AD: Atypical Antipsychotics Linked to Weight Gain in Older Women
Medscape - Apr 23, 2009
At randomization, 46% were using antihypertensive agents, 60% were taking a cholinesterase inhibitor or memantine, 24% were on cholesterol-lowering ...
|
|
|
|
|